Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Endoskopie in Österreich (Stand 2010)
Kardiologie in Österreich (Stand 2006)
Osteologie in Österreich (Stand 2016)
Fachbücher
Patientenliteratur
Gasser R, Klein W, Köppel H Lercanidipine, a new third generation Ca-antagonist in the treatment of hypertension Journal of Clinical and Basic Cardiology 1999; 2 (2): 169-174 PDF Summary Overview
| ||||
Figure/Graphic 2: Lercanidipin - systolischer und diastolischer Blutdruck Mean supine systolic and diastolic blood pressure and heart rate at baseline and after 30, 60 and 90 days treatment with lercanidipine 20-40 mg once (n = 16; diamonds) or twice daily (n = 20; squares) (redrawn according to [46]) |
Figure/Graphic 2: Lercanidipin - systolischer und diastolischer Blutdruck
Mean supine systolic and diastolic blood pressure and heart rate at baseline and after 30, 60 and 90 days treatment with lercanidipine 20-40 mg once (n = 16; diamonds) or twice daily (n = 20; squares) (redrawn according to [46]) |